The requested tables cannot be built from the supplied evidence. None of the provided claim-level records describe a skin and soft tissue infection (SSTI) cohort, SSTI subtype classification, patient age strata, malignancy distribution, or any sample of n=227. The available records cover: (1) LDOC1/EGFR trafficking in NSCLC (n=200 tumor cohort) ; (2) SstI restriction enzyme lambda vectors; (3) EGFR copy-number screening in lung adenocarcinoma (n=96) ; (4) apoC3 SstI polymorphism and atherosclerosis (n=628) ; and (5) FUT8/EGFR antiviral immunity. "SstI" here refers to the restriction endonuclease from Streptomyces stanfordii, not SSTI (skin and soft tissue infection) β a likely keyword collision.
What is missing: the specific source paper with n=227 reporting SSTI types, age, and malignancy distribution. Please upload or link that paper (PDF or DOI); once supplied, the tables and distributions can be constructed directly.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.